Image

Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea.

Eligibility

Inclusion Criteria:

  1. Informed consent obtained
  2. Three groups will be enrolled:
    1. HFpEF (cardiologist-adjudicated diagnosis as verified by PI, EF≥50%)
    2. Non-cardiac dyspnea (patients have dyspnea but were found on invasive exercise testing not to have HFpEF).
    3. Healthy volunteers with no history of dyspnea or effort intolerance.

Exclusion Criteria:

  1. Contraindication for low-field CMR, as indicated in MRI safety screening checklist (Research Document #1)
  2. Patient inability or unwillingness to undergo Ex-CMR
  3. Cardiac implants, mechanical or biological valve, causing artifacts that compromise the quality of data
  4. Hospitalization for heart failure in the preceding 30 days.
  5. Large R-R interval variation, caused by frequent premature ventricular contractions or non-sinus rhythms such as persistent atrial fibrillation, which, in the opinion of the investigators, compromises the quality of data acquisition, image analysis and disrupts the consistency of the cohorts
  6. Myocardial infarction or unstable angina pectoris
  7. Planned coronary, carotid, or peripheral artery revascularization
  8. Other causes of dyspnea as indicated in patients' medical history based upon the opinion of the PI, such as restrictive cardiomyopathy or infiltrative conditions (e.g., amyloidosis), hypertrophic obstructive cardiomyopathy, primary pulmonary arterial hypertension, more than moderate chronic obstructive pulmonary disease, right heart failure due to pulmonary disease, complex congenital heart disease, severe anemia, or more than moderate mitral or aortic heart valve disease).

Study details
    Heart Failure With Preserved Ejection Fraction

NCT07401771

Mayo Clinic

14 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.